{"prompt": "['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', 'Appendix 8 Decision Tree for Re-treatment - Part A', 'DO NOT RE-TREAT', 'NO', 'NO', 'OUTSIDE', 'MG-ADL', 'LATER THAN', 'NO', 'YES', 'YES', 'TREAT. CYCLE', '5', 'YES', 'D127', 'NO', 'RE-TREAT\u00b2', 'RE-TREAT', '(in ARGX-113-', '(Roll over to', '1704)', 'ARGX-113-1705)', 'NO', 'RESPONSE', 'OUTSIDE', 'MG-ADL', 'LATER THAN', 'YES', 'YES', 'YES', 'YES', 'LOST\u00b3', 'TREAT. CYCLE', '5', 'D127', 'YES', 'NO', 'NO', 'NO', 'DO NOT RE-TREAT', '1', 'MG-ADL decrease of > 2 points (compared to the corresponding TC baseline) for at least 4 consecutive weeks', 'with the first of these decreases occurring at the latest 1 week after last infusion of IMP of the corresponding', 'cycle.', '2 Retreat at the first timepoint when all re-treatment conditions apply and if no infection or confounding', 'conditions exist (see also section 4.1).', '3', 'MG-ADL decrease of < 2 compared to corresponding TC baseline.', 'argenx BVBA', 'Confidential', 'Page 109 of 110']['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', 'Appendix 9 Decision Tree for Re-treatment - Part B', 'Patient in NEED of retreatment', 'Evidence of infections or any', 'other relevant conditions\u00b9', 'NO', 'YES', 'Re-treat with', 'IMP', 'Use', 'Postpone', 'IMP\u00b2', 'Re-treatment', 'Change in', 'Use other', 'Standard Of Care', 'MG treatments3', 'Use prohibited', 'medications', '1', 'Conditions that may interfere with the correct interpretation of the data or put the patient at undue risk.', '2', 'Re-treatment with IMP may be reconsidered at next time where conditions for re-treatment are met, providing', 'that at least 4 weeks have past after other MG treatment.', '3 Provided that it is not a SoC or a prohibited medication.', 'argenx BVBA', 'Confidential', 'Page 110 of 110']\n\n###\n\n", "completion": "END"}